BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3133249)

  • 1. The importance of human chorionic gonadotropin support of the corpus luteum during human gonadotropin therapy in women with anovulatory infertility.
    Messinis IE; Bergh T; Wide L
    Fertil Steril; 1988 Jul; 50(1):31-5. PubMed ID: 3133249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotropin therapy of female infertility. Analysis of results in 416 cases.
    Zimmermann R; Soor B; Braendle W; Lehmann F; Weise HC; Bettendorf G
    Gynecol Obstet Invest; 1982; 14(1):1-18. PubMed ID: 6811376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of ovarian follicular and luteal function during treatment with exogenous gonadotropins in anovulatory infertility.
    Yuen BH; Sy L; Cannon W
    Am J Obstet Gynecol; 1981 Jul; 140(6):629-35. PubMed ID: 6167169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of progesterone/estradiol ratio on luteal function for achieving pregnancy in gonadotropin therapy.
    Kamada S; Kubota T; Aso T
    Horm Res; 1992; 37 Suppl 1():59-63. PubMed ID: 1427631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luteal dysfunction in ovulation induction: the role of repetitive human chorionic gonadotropin supplementation during the luteal phase.
    Blumenfeld Z; Nahhas F
    Fertil Steril; 1988 Sep; 50(3):403-7. PubMed ID: 3137096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of HMG (Humegon)-HCG therapy in 6096 treatment cycles of 2166 Japanese women with anovulatory infertility.
    Kurachi K; Aono T; Suzuki M; Hirano M; Kobayashi T; Kaibara M
    Eur J Obstet Gynecol Reprod Biol; 1985 Jan; 19(1):43-51. PubMed ID: 3920090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous pregnancy and its outcome after human menopausal gonadotropin/human chorionic gonadotropin-induced pregnancy.
    Ben-Rafael Z; Mashiach S; Oelsner G; Farine D; Lunenfeld B; Serr DM
    Fertil Steril; 1981 Nov; 36(5):560-4. PubMed ID: 6796437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary report about a modified gonadotropin (human menopausal gonadotropin/human chorionic gonadotropin) treatment in infertile patients with premature luteinization.
    Zimmermann R; Bohnet HG; Weise HC; Leidenberger FA
    Fertil Steril; 1984 May; 41(5):714-8. PubMed ID: 6425086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shortened luteal phase after ovulation induction with human menopausal gonadotropin and human chorionic gonadotropin.
    Olson JL; Rebar RW; Schreiber JR; Vaitukaitis JL
    Fertil Steril; 1983 Mar; 39(3):284-91. PubMed ID: 6402386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luteal phase support with hCG does not improve fecundity rate in human menopausal gonadotropin-stimulated cycles.
    Keenan JA; Moghissi KS
    Obstet Gynecol; 1992 Jun; 79(6):983-7. PubMed ID: 1579327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observations on the combination of clomiphene citrate-human menopausal gonadotropin-human chorionic gonadotropin in the management of anovulation.
    Jarrell J; McInnes R; Cooke R; Arronet G
    Fertil Steril; 1981 Jun; 35(6):634-7. PubMed ID: 6788606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buserelin suppression of endogenous gonadotropin secretion in infertile women with ovarian feedback disorders given human menopausal/human chorionic gonadotropin treatment.
    Weise HC; Fiedler K; Kato K
    Fertil Steril; 1988 Mar; 49(3):399-403. PubMed ID: 3125067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of luteal support with progesterone in gonadotropin-induced cycles.
    Hamilton CJ; Jaroudi KA; Sieck UV
    Fertil Steril; 1993 Nov; 60(5):786-90. PubMed ID: 8224262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anovulatory sterility. Treatment with human menopausal gonadotropin and human chorionic gonadotropin].
    Espersen T; Møller J; Hansen KP
    Ugeskr Laeger; 1984 Feb; 146(9):640-3. PubMed ID: 6424295
    [No Abstract]   [Full Text] [Related]  

  • 15. Single-versus multiple-dose human chorionic gonadotropin for ovulation induction: effect on luteal function and pregnancy rate.
    James C; Barrow S; Yuen BH
    Fertil Steril; 1991 May; 55(5):1008-10. PubMed ID: 2022258
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum 17beta-estradiol. Index of follicular maturation during gonadotropin therapy.
    Notation AD; Tagatz GE; Steffes MW
    Obstet Gynecol; 1978 Feb; 51(2):204-9. PubMed ID: 622235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma hormones in human gonadotropin induced ovulation.
    Wu CH
    Obstet Gynecol; 1977 Mar; 49(3):308-13. PubMed ID: 840459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evidence of luteotropic activity of chorionic gonadotropin in patients with controlled ovarian stimulation].
    Kably Ambe A; González Cervantes MM; Barrón Vallejo J; Serviere Zaragoza C; Cherem Cherem B
    Ginecol Obstet Mex; 1995 Jul; 63():308-11. PubMed ID: 7665118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luteinizing hormone bioactivity in human menopausal gonadotropin/human chorionic gonadotropin-induced cycles.
    Abuzeid MI; Yeoman R; Aksel S
    Fertil Steril; 1987 Feb; 47(2):238-43. PubMed ID: 3102284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The luteal phase during gonadotropin therapy: effects of two human chorionic gonadotropin regimens.
    Grazi RV; Taney FH; Gagliardi CL; Von Hagen S; Weiss G; Schmidt CL
    Fertil Steril; 1991 Jun; 55(6):1088-92. PubMed ID: 1903727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.